Explore
Multimedia
-
February 13, 2024
BioAge Labs Raises $170m to Develop Therapies Using AI
-
January 4, 2023
Virtual KOL event: Positive Ph1b topline muscle atrophy data for BGE-105 & design of Phase 2 trial
-
November 17, 2022
Investing in the Age of Longevity
-
November 14, 2022
BioAge's unique approach to targeting aging